Rev Bras Cir Cardiovasc 2013;28(2):292-5 Feng Z, et al. -Extracorporeal membrane oxygenation as a support for TGA/ IVS with low cardiac output syndrome and pulmonary hemorrhage RBCCV 44205-1470 DOI: 10.5935/1678 Extracorporeal membrane oxygenation as a support for TGA/IVS with low cardiac output syndrome and pulmonary hemorrhage SHORT COMMUNICATION Abstract A 15-day-old neonate with complete transposition of the great arteries/intact ventricular septum was admitted with lifethreatening hypoxemia and heart arrest. After successful resuscitation, heart beat recovered but blood lactate began to arise and maintained above 15 mmol/L 6 hours later. Emergency arterial switch operation was done at 20 hours after resuscitation. Planned extracorporeal membrane oxygenation support was employed postoperatively. The baby experienced severe pulmonary hemorrhage and severe hypoxemia after weaning from cardiopulmonary bypass, which were treated with extracorporeal membrane oxygenation support. 
INTRODUCTION
Arterial switch operation (ASO) has long been as a treatment of choice for neonates with transposition of the great arteries/intact ventricular septum (TGA/IVS) achieving favorable clinical outcome. Unfortunately, in some patients, the treatment of TGA/IVS is usually delayed. Under this condition, the ASO was inapplicable for them, because the left ventricle is unable to accommodate the systemic pressure [1] . Here in, we reported our experience in the treatment 
CLINICAL CASE
A male neonate with TGA/IVS was admitted into the Pediatric Cardiac Intensive Care Unit (PCICU) of our hospital due to life threatening hypoxemia. He was 15-day old and 3.6 kg in body weight on admission. Patent foramen and patent ductus arteriosus were normal (2 mm and 2.3 mm in diameter, respectively) and the ventricular septum obviously deviated to the left ventricle by bed-side trans-thoracic echocardiography. Blood gas analysis showed the partial pressure of carbon dioxide (PCO 2 ) and partial pressure of oxygen (PO 2 ) was 37 mmHg and 9 mmHg, respectively, the lactate level was 1.5 mmol/L on admission. The prostaglandin E1 was used immediately after admission. At 5 hours after admission, the PCO 2 and PO 2 were 51 mmHg and 7 mmHg, respectively, and the lactate level was 7.0 mmol/L as shown in arterial blood gas analysis. At 10 hours after admission, heart arrest occurred. After resuscitation, inotropic agents (dopamine and epinephrine) were continuously infused. The lactate level gradually increased to 13.6 mmol/L, and PO 2 was elevated to 9 mmHg.
At 19 hours after admission, this patient received ASO under moderate hypothermia CPB with ultrafiltration. The blood flow in cardiopulmonary bypass (CPB) was adjusted from 150 to 200 ml/kg/min, and the activated clotting time (ACT) was controlled from 450 s to 650 s. The lactate level was maintained at >15 mmol/L for 9 hours and the LV/RV at 0.5 hour before surgery. The time of aorta cross clamp and total CPB was 80 min and 175 min, respectively. After releasing of aortic clamp, the heart beat with sinus rhythm was observed at 130 beats/min. After surgery, the lactate level was still at a high level (>15 mmol/L), and pulmonary hemorrhage occurred. The estimated amount of blood loss from the trachea tube was 100 ml.
Then, the positive end-expiratory pressure (PEEP) was increased from 3 cm H 2 O to 8 cm H 2 O aiming to control the pulmonary hemorrhage. The heart beat or blood pressure was unstable although the volume load and hematocrit (Hct=31%) was acceptable and inotropic agents (dopamine: 10 μg/ kg/min, epinephrine: 0.15 μg/kg.min) were continuously infused during the weaning from CPB. Because of LCOS and pulmonary hemorrhage, extracorporeal membrane oxygenation (ECMO) was prepared for cardiopulmonary support. A 10-Fr aortal cannula and a 16-Fr right atrium cannula were cut off from the CPB system and connected to the ECMO circuit immediately (Medtronic Inc. Minneapolis, MN, USA). The ECMO system was composed of a heparin-
Fig. 2 -A: Anteroposterior chest X-ray (POD1 after ECMO initiation). B: Anteroposterior chest X-ray (POD6 after ECMO discontinuation)
coated circuit, hollow fiber oxygenator and centrifugal pump (Medtronic Inc. Minneapolis, MN, USA). The ECMO blood flow rate was maintained at 0.6 l/min and this neonate was transferred to PCICU with delayed wound closure.
The serum lactate level was still remained at >15 mmol/L for 9 hours after surgery in PCICU, and there after decreased gradually. The lactate level was 2.2 mmol/L at 25 hours after surgery (Figure 1) . The patient regained clear consciousness at 16 hours. With favorable urine output, acceptable arterial blood pressure (70-80/30-40 mmHg) and favorable findings in chest X-ray (Figure 2A and 2B) , the patient weaned off the ECMO after 96 hours support, and the wound was closed simultaneously. During the ECMO support, heparin was used to maintain ACT at 160-250 s. Platelets were infused daily to keep the platelet level at >50000/L. This patient was extubated at 6 days after operation and discharged eventually.
DISCUSSION
Now, ASO is the treatment of choice for TGA/IVS in neonates. However, in China, the treatment of TGA/ IVS is usually delayed and the pulmonary arterial pressure is significantly declined in these neonates. Thus, the left ventricle is unable to accommodate the systemic pressure after ASO. Under this situation, rather than ASO, two-stage ASO is performed [1] . However, many authors thought that the degradation of left ventricle was reversible, and were more inclined to perform primary ASO followed by ECMO support [2] [3] [4] .
In the present case, the patient gradually deteriorated after admission, and the life-threatening hypoxemia resulted in cardiac arrest and high level lactate. We speculated that the patent ductus arteriosus (PDA) was almost closed. Echocardiography after admission showed the ventricular septal obviously deviated to the left ventricle. Considering this, rapid two-stage ASO was infeasible for this patient. Thus, ECMO was prepared before ASO. Although the use of EMCO-based left ventricle support for TGA/IVS after ASO has been reported previously [5] , to our knowledge EMCO used in such critical TGA/IVS patient who had high level lactate (>15 mmol/L) before ASO and pulmonary hemorrhage after ASO has not been reported in previous studies.
In this patient, the ventricular septum deviated toward the left, and the LV/RV was 0.5, suggesting that the left ventricle may not endure the systemic pressure if the ASO is performed under CPB. On the other hand, life-threatening hypoxemia and high lactate level might make his cardiopulmonary function worse after operation, and rapid two-stage ASO was not feasible for life-saving. Because ECMO is able to provide both cardiac and pulmonary support immediately, ECMO was performed after the ASO was finished, and pulmonary hemorrhage was found. ECMO was performed as soon as CPB discontinued. Massive transfusion had to be done, and this resulted in hypothermia, which may recover after treatment with the heat-exchanger of the ECMO system. The time of initiation of ECMO is crucial for life saving.
In this case, ECMO was performed as soon as possible in the operation room. Recent reports [6, 7] revealed that ECMO in operation room could avoid the prolonged hypoperfusion and multiorgan failure. In the support with ECMO, the heparincoated circuit could omit the use of heparin, and platelets were transfused daily to keep the platelet at > 50000/L, which may improve the coagulation. After 92 hours ECMO support, this patient's hemodynamics was stable enough and weaned from ECMO. Then, the wound was closed in the PCICU.
